← Eichor
Condition: Vorolanib Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vorolanib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07386158Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Phase N/A · 1 location(s) · Jinling Hospital, China · NCT06676527Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Pa
Phase 2 · 1 location(s) · Li-kun Chen · NCT06728852
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.